272 related articles for article (PubMed ID: 21571356)
1. IκB kinase-driven nuclear factor-κB activation in patients with asthma and chronic obstructive pulmonary disease.
Gagliardo R; Chanez P; Profita M; Bonanno A; Albano GD; Montalbano AM; Pompeo F; Gagliardo C; Merendino AM; Gjomarkaj M
J Allergy Clin Immunol; 2011 Sep; 128(3):635-45.e1-2. PubMed ID: 21571356
[TBL] [Abstract][Full Text] [Related]
2. Regulation and function of IKK and IKK-related kinases.
Häcker H; Karin M
Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
[TBL] [Abstract][Full Text] [Related]
3. Magnolol suppresses NF-kappaB activation and NF-kappaB regulated gene expression through inhibition of IkappaB kinase activation.
Tse AK; Wan CK; Zhu GY; Shen XL; Cheung HY; Yang M; Fong WF
Mol Immunol; 2007 Apr; 44(10):2647-58. PubMed ID: 17240450
[TBL] [Abstract][Full Text] [Related]
4. Validation of the anti-inflammatory properties of small-molecule IkappaB Kinase (IKK)-2 inhibitors by comparison with adenoviral-mediated delivery of dominant-negative IKK1 and IKK2 in human airways smooth muscle.
Catley MC; Sukkar MB; Chung KF; Jaffee B; Liao SM; Coyle AJ; Haddad el-B; Barnes PJ; Newton R
Mol Pharmacol; 2006 Aug; 70(2):697-705. PubMed ID: 16687566
[TBL] [Abstract][Full Text] [Related]
5. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
Tse AK; Wan CK; Shen XL; Yang M; Fong WF
Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613
[TBL] [Abstract][Full Text] [Related]
6. [Effect of phosphodiesterase inhibitor on expression of IL-8 mRNA in peripheral blood mononuclear cells from COPD patients].
Yang DL; Xu YJ; Zhang ZX; Li CQ; Ni W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 May; 21(3):359-61. PubMed ID: 15862158
[TBL] [Abstract][Full Text] [Related]
7. Classical NF-κB activation impairs skeletal muscle oxidative phenotype by reducing IKK-α expression.
Remels AH; Gosker HR; Langen RC; Polkey M; Sliwinski P; Galdiz J; van den Borst B; Pansters NA; Schols AM
Biochim Biophys Acta; 2014 Feb; 1842(2):175-85. PubMed ID: 24215713
[TBL] [Abstract][Full Text] [Related]
8. Reduced nuclear factor-κB repressing factor: a link toward systemic inflammation in COPD.
Lee KY; Ho SC; Chan YF; Wang CH; Huang CD; Liu WT; Lin SM; Lo YL; Chang YL; Kuo LW; Kuo HP
Eur Respir J; 2012 Oct; 40(4):863-73. PubMed ID: 22441735
[TBL] [Abstract][Full Text] [Related]
9. Smoke, choline acetyltransferase, muscarinic receptors, and fibroblast proliferation in chronic obstructive pulmonary disease.
Profita M; Bonanno A; Siena L; Bruno A; Ferraro M; Montalbano AM; Albano GD; Riccobono L; Casarosa P; Pieper MP; Gjomarkaj M
J Pharmacol Exp Ther; 2009 May; 329(2):753-63. PubMed ID: 19190237
[TBL] [Abstract][Full Text] [Related]
10. Repression of inflammatory gene expression in human pulmonary epithelial cells by small-molecule IkappaB kinase inhibitors.
Newton R; Holden NS; Catley MC; Oyelusi W; Leigh R; Proud D; Barnes PJ
J Pharmacol Exp Ther; 2007 May; 321(2):734-42. PubMed ID: 17322026
[TBL] [Abstract][Full Text] [Related]
11. Enterovirus 71 2C protein inhibits TNF-α-mediated activation of NF-κB by suppressing IκB kinase β phosphorylation.
Zheng Z; Li H; Zhang Z; Meng J; Mao D; Bai B; Lu B; Mao P; Hu Q; Wang H
J Immunol; 2011 Sep; 187(5):2202-12. PubMed ID: 21810613
[TBL] [Abstract][Full Text] [Related]
12. Systemic inflammation in chronic obstructive pulmonary disease and asthma: Similarities and differences.
Higashimoto Y; Yamagata Y; Taya S; Iwata T; Okada M; Ishiguchi T; Sato H; Itoh H
Respirology; 2008 Jan; 13(1):128-33. PubMed ID: 18197923
[TBL] [Abstract][Full Text] [Related]
13. [Influence of nuclear factor-kappaB activation on the expression of cytokines in monocytes stimulated by burn serum].
Li ZQ; Huang YS; Yang ZC; Wang JH
Zhonghua Shao Shang Za Zhi; 2005 Dec; 21(6):434-7. PubMed ID: 16480624
[TBL] [Abstract][Full Text] [Related]
14. The effects of genistein and puerarin on the activation of nuclear factor-kappaB and the production of tumor necrosis factor-alpha in asthma patients.
Liu XJ; Zhao J; Gu XY
Pharmazie; 2010 Feb; 65(2):127-31. PubMed ID: 20225658
[TBL] [Abstract][Full Text] [Related]
15. cis-9,trans-11-conjugated linoleic acid down-regulates phorbol ester-induced NF-kappaB activation and subsequent COX-2 expression in hairless mouse skin by targeting IkappaB kinase and PI3K-Akt.
Hwang DM; Kundu JK; Shin JW; Lee JC; Lee HJ; Surh YJ
Carcinogenesis; 2007 Feb; 28(2):363-71. PubMed ID: 16950795
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1-induced NF-kappaB activation is NEMO-dependent but does not require IKKbeta.
Solt LA; Madge LA; Orange JS; May MJ
J Biol Chem; 2007 Mar; 282(12):8724-33. PubMed ID: 17244613
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of inflammatory cytokine production from rheumatoid synovial fibroblasts by a novel IkappaB kinase inhibitor.
Tsuchiya A; Imai K; Asamitsu K; Waguri-Nagaya Y; Otsuka T; Okamoto T
J Pharmacol Exp Ther; 2010 Apr; 333(1):236-43. PubMed ID: 20053934
[TBL] [Abstract][Full Text] [Related]
18. N-tosyl-L-phenylalanine chloromethyl ketone inhibits NF-kappaB activation by blocking specific cysteine residues of IkappaB kinase beta and p65/RelA.
Ha KH; Byun MS; Choi J; Jeong J; Lee KJ; Jue DM
Biochemistry; 2009 Aug; 48(30):7271-8. PubMed ID: 19591457
[TBL] [Abstract][Full Text] [Related]
19. NEMO-binding domains of both IKKalpha and IKKbeta regulate IkappaB kinase complex assembly and classical NF-kappaB activation.
Solt LA; Madge LA; May MJ
J Biol Chem; 2009 Oct; 284(40):27596-608. PubMed ID: 19666475
[TBL] [Abstract][Full Text] [Related]
20. NF-kappaB Signaling in Chronic Inflammatory Airway Disease.
Schuliga M
Biomolecules; 2015 Jun; 5(3):1266-83. PubMed ID: 26131974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
